Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Immunology
Published in: BMC Immunology 1/2021

Open Access 01-12-2021 | Research

Factors associated with IgG levels in adults with IgG subclass deficiency

Authors: James C. Barton, Jackson Clayborn Barton, Luigi F. Bertoli, Ronald T. Acton

Published in: BMC Immunology | Issue 1/2021

Login to get access

Abstract

Background

Factors associated with IgG levels in adults with IgG subclass deficiency (IgGSD) are incompletely understood. We studied adults with IgGSD with subnormal IgG1 only, subnormal IgG1/IgG3, or subnormal IgG3 only without other subnormal IgG subclasses, IgA, or IgM. We compiled: age; sex; autoimmune condition(s) (AC); atopy; IgG, IgG subclasses, IgA, IgM; IgGsum (IgG1 + IgG2 + IgG3 + IgG4); and D (percentage difference between IgGsum and IgG). We compared attributes of patients with/without subnormal IgG (< 7.00 g/L; subnormal IgG1 subclass groups only) and analyzed IgGsum and IgG relationships. We performed backward stepwise regressions on IgG using independent variables IgG subclasses, age, and sex and on D using independent variables age and sex.

Results

There were 39 patients with subnormal IgG1 only (89.7% women), 53 with subnormal IgG1/IgG3 (88.7% women), and 115 with subnormal IgG3 only (91.3% women). Fifteen patients (38.5%) and 32 patients (60.4%) in the respective subnormal IgG1 subclass groups had subnormal IgG. Attributes of patients with/without IgG < 7.00 g/L were similar, except that AC prevalence was lower in patients with subnormal IgG1 only and IgG < 7.00 g/L than ≥ 7.00 g/L (p = 0.0484). Mean/median IgG1 and IgG2 were significantly lower in patients with IgG < 7.00 g/L in both subnormal IgG1 subclass groups (p < 0.0001, all comparisons). Regressions on IgG in three subclass groups revealed positive associations with IgG1 and IgG2 (p < 0.0001 each association). Regressions on D revealed no significant association. IgG1 percentages of IgGsum were lower and IgG2 percentages were higher in patients with subnormal IgG1 subclass levels than subnormal IgG3 only (p < 0.0001 all comparisons).

Conclusions

We conclude that both IgG1 and IgG2 are major determinants of IgG in patients with subnormal IgG1, combined subnormal IgG1/IgG3, or subnormal IgG3 and that in patients with subnormal IgG1 or combined subnormal IgG1/IgG3, median IgG2 levels are significantly lower in those with IgG < 7.00 g/L than those with IgG ≥ 7.00 g/L.
Appendix
Available only for authorised users
Literature
1.
2.
French MA, Harrison G. Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol. 1984;56:473–5.PubMedPubMedCentral
3.
4.
5.
Van Kessel DA, Horikx PE, Van Houte AJ, De Graaff CS, Van Velzen-Blad H, Rijkers GT. Clinical and immunological evaluation of patients with mild IgG1 deficiency. Clin Exp Immunol. 1999;118:102–7.PubMedPubMedCentralCrossRef
6.
Barton JC, Bertoli LF, Barton JC, Acton RT. Selective subnormal IgG1 in 54 adult index patients with frequent or severe bacterial respiratory tract infections. J Immunol Res. 2016;1405950.
7.
Hashira S, Okitsu-Negishi S, Yoshino K. Placental transfer of IgG subclasses in a Japanese population. Pediatr Int. 2000;42:337–42.PubMedCrossRef
8.
Stapleton NM, Brinkhaus M, Armour KL, Bentlage AEH, de Taeye SW, Temming AR, et al. Reduced FcRn-mediated transcytosis of IgG2 due to a missing glycine in its lower hinge. Sci Rep. 2019;9:7363.PubMedPubMedCentralCrossRef
9.
Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med. 1980;303:178–82.PubMedCrossRef
10.
Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol. 1986;63:127–34.PubMedPubMedCentral
11.
Kojima K, Ishizaka A, Oshika E, Taguchi Y, Tomizawa K, Nakanishi M, et al. Quantitation of IgG subclass antibodies to pneumococcal capsular polysaccharides by ELISA, using Pneumovax-specific antibodies as a reference. Tohoku J Exp Med. 1990;161:209–15.PubMedCrossRef
12.
Schauer U, Stemberg F, Rieger CH, Buttner W, Borte M, Schubert S, et al. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol. 2003;10:202–7.PubMedPubMedCentral
13.
Oxelius VA. Chronic infections in a family with hereditary deficiency of IgG2 and IgG4. Clin Exp Immunol. 1974;17:19–27.PubMedPubMedCentral
14.
Braconier JH, Nilsson B, Oxelius VA, Karup-Pedersen F. Recurrent pneumococcal infections in a patient with lack of specific IgG and IgM pneumococcal antibodies and deficiency of serum IgA, IgG2 and IgG4. Scand J Infect Dis. 1984;16:407–10.PubMedCrossRef
15.
Stanley PJ, Corbo G, Cole PJ. Serum IgG subclasses in chronic and recurrent respiratory infections. Clin Exp Immunol. 1984;58:703–8.PubMedPubMedCentral
16.
Barton JC, Barton JC, Bertoli LF, Acton RT. Characterization of adult patients with IgG subclass deficiency and subnormal IgG2. PLoS ONE. 2020;15:e0240522.PubMedPubMedCentralCrossRef
17.
Morell A, Skvaril F, Steinberg AG, Van LE, Terry WD. Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera. J Immunol. 1972;108:195–206.PubMedCrossRef
18.
19.
Abrahamian F, Agrawal S, Gupta S. Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin Exp Immunol. 2010;159:344–50.PubMedPubMedCentralCrossRef
20.
Barton JC, Bertoli LF, Barton JC, Acton RT. Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections. Cell Immunol. 2016;299:50–7.PubMedCrossRef
21.
Khokar A, Gupta S. Clinical and immunological features of 78 adult patients with primary selective IgG subclass deficiencies. Arch Immunol Ther Exp (Warsz). 2019;67:325–34.CrossRef
22.
Soderström T, Soderström R, Avanzini A, Brandtzaeg P, Karlsson G, Hanson LA. Immunoglobulin G subclass deficiencies. Int Arch Allergy Appl Immunol. 1987;82:476–80.PubMedCrossRef
23.
Aghamohammadi A, Lougaris V, Plebani A, Miyawaki T, Durandy A, Hammarström L: Predominantly antibody deficiencies. Edited by Rezaei N, Aghamohammadi A, Notarangelo LD. Berlin: Springer-Verlag; 2008:97–130.
24.
Kim JH, Park HJ, Choi GS, Kim JE, Ye YM, Nahm DH, et al. Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. J Korean Med Sci. 2010;25:824–8.PubMedPubMedCentralCrossRef
25.
Barton JC, Bertoli LF, Barton JC. Comparisons of CVID and IgGSD: referring physicians, autoimmune conditions, pneumovax reactivity, immunoglobulin levels, blood lymphocyte subsets, and HLA-A and -B typing in 432 adult index patients. J Immunol Res. 2014;2014:542706.PubMedPubMedCentralCrossRef
26.
27.
Pasternak G, Lewandowicz-Uszynska A, Pentos K. Analysis of differences between total IgG and sum of the IgG subclasses in children with suspected immunodeficiency—indication of determinants. BMC Immunol. 2018;19:22.PubMedPubMedCentralCrossRef
28.
Morell A, Skvaril F: A modified radioimmunoassay for quantitative determination of IgG subclasses in man. In Protides of Biological Fluids (vol. 19). Edited by Peeters H. London: 1971:533–540.
29.
van der Giessen M, Rossouw E, van Veen TA, Van LE, Zegers BJ, Sander PC. Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Immunol. 1975;21:501–9.PubMedPubMedCentral
30.
Madassery JV, Kwon OH, Lee SY, Nahm MH. IgG2 subclass deficiency: IgG subclass assays and IgG2 concentrations among 8015 blood donors. Clin Chem. 1988;34:1407–13.PubMedCrossRef
31.
Marsh RA, Orange JS. Antibody deficiency testing for primary immunodeficiency: a practical review for the clinician. Ann Allergy Asthma Immunol. 2019;123:444–53.PubMedCrossRef
32.
Maguire GA, Kumararatne DS, Joyce HJ. Are there any clinical indications for measuring IgG subclasses? Ann Clin Biochem. 2002;39:374–7.PubMedCrossRef
33.
Zhang H, Li P, Wu D, Xu D, Hou Y, Wang Q, et al. Serum IgG subclasses in autoimmune diseases. Medicine (Baltimore). 2015;94:e387.CrossRef
34.
Liu Y, Li J. Preferentially immunoglobulin (IgG) subclasses production in primary Sjogren’s syndrome patients. Clin Chem Lab Med. 2011;50:345–9.PubMed
35.
Lin GG, Li JM. IgG subclass serum levels in systemic lupus erythematosus patients. Clin Rheumatol. 2009;28:1315–8.PubMedCrossRef
36.
Lefranc MP, Lefranc G. Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism. Methods Mol Biol. 2012;882:635–80.PubMedCrossRef
37.
Review of the notation for the allotypic and related markers of human immunoglogulins. J Immunol. 1976;117:1056–1058.
38.
Nahm MH, Macke K, Kwon OH, Madassery JV, Sherman LA, Scott MG. Immunologic and clinical status of blood donors with subnormal levels of IgG2. J Allergy Clin Immunol. 1990;85:769–77.
39.
Cox DW, Markovic VD, Teshima IE. Genes for immunoglobulin heavy chains and for alpha 1-antitrypsin are localized to specific regions of chromosome 14q. Nature. 1982;297:428–30.PubMedCrossRef
40.
Lefranc MP, Lefranc G, Rabbitts TH. Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals. Nature. 1982;300:760–2.PubMedCrossRef
41.
Lefranc G, Chaabani H, van Loghem E, Lefranc MP, de Gerda L, Helal AN. Simultaneous absence of the human IgG1, IgG2, IgG4 and IgA1 subclasses: immunological and immunogenetical considerations. Eur J Immunol. 1983;13:240–4.PubMedCrossRef
42.
Migone N, Oliviero S, de Gerda L, Delacroix DL, Boschis D, Altruda F, et al. Multiple gene deletions within the human immunoglobulin heavy-chain cluster. Proc Natl Acad Sci USA. 1984;81:5811–5.PubMedPubMedCentralCrossRef
43.
Keyeux G, Lefranc G, Lefranc MP. A multigene deletion in the human IGH constant region locus involves highly homologous hot spots of recombination. Genomics. 1989;5:431–41.PubMedCrossRef
44.
45.
Lacombe C, Aucouturier P, Preud’homme JL. Selective IgG1 deficiency. Clin Immunol Immunopathol. 1997;84:194–201.PubMedCrossRef
46.
Aucouturier P, Lacombe C, Preud’homme JL. Serum IgG subclass level determination: methodological difficulties and practical aspects. Ann Biol Clin. 1994;52:53–6.
47.
Hammarström L, Smith CI. IgG2 deficiency in a healthy blood donor. Concomitant lack of IgG2, IgA and IgE immunoglobulins and specific anti-carbohydrate antibodies. Clin Exp Immunol. 1983;51:600–4.PubMedPubMedCentral
48.
Kuijpers TW, Weening RS, Out TA. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens. Allergol Immunopathol (Madr ). 1992;20:28–34.
49.
Damelang T, Rogerson SJ, Kent SJ, Chung AW. Role of IgG3 in infectious diseases. Trends Immunol. 2019;40:197–211.PubMedCrossRef
50.
Barton JC, Bertoli LF, Acton RT. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y. Blood Cells Mol Dis. 2003;31:102–11.PubMedCrossRef
51.
Bertoli LF, Pappas DG, Barton JC, Barton JC. Serum immunoglobulins in 28 adults with autoimmune sensorineural hearing loss: increased prevalence of subnormal immunoglobulin G1 and immunoglobulin G3. BMC Immunol. 2014;15:43.PubMedPubMedCentralCrossRef
52.
Barton JC, Barton JC, Cruz E, Teles MJ, Guimaraes JT, Porto G. Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity. Blood Cells Mol Dis. 2020;85:102461.PubMedCrossRef
53.
McLean-Tooke A, O’Sullivan M, Easter T, Loh R. Differences between total IgG and sum of the IgG subclasses in clinical samples. Pathology. 2013;45:675–7.PubMedCrossRef
54.
Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287–93.PubMedCrossRef
55.
Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, et al. Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA. 2011;306:2331–9.PubMedPubMedCentralCrossRef
56.
Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. 2013;22:1286–94.PubMedCrossRef
57.
Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford). 2013;52:53–61.CrossRef
58.
Quartuccio L, Zabotti A, Del ZS, Zanier L, De VS, Valent F. Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data. J Adv Res. 2019;15:87–93.PubMedCrossRef
59.
Juhn YJ, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008;122:719–23.PubMedPubMedCentralCrossRef
60.
Jung JA, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, et al. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol. 2010;125:217–21.PubMedPubMedCentralCrossRef
61.
Rantala A, Jaakkola JJ, Jaakkola MS. Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens. PLoS ONE. 2013;8:e68582.PubMedPubMedCentralCrossRef
62.
Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol. 2014;134:247–57.PubMedPubMedCentralCrossRef
63.
Rantala A, Lajunen T, Juvonen R, Bloigu A, Silvennoinen-Kassinen S, Peitso A, et al. Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J Infect Dis. 2008;198:1247–53.PubMedCrossRef
64.
Barton JC, Barton JC, Bertoli LF. Clinical and laboratory associations of mannose-binding lectin in 219 adults with IgG subclass deficiency. BMC Immunol. 2019;20:15.PubMedPubMedCentralCrossRef
65.
Smith JK, Krishnaswamy GH, Dykes R, Reynolds S, Berk SL. Clinical manifestations of IgE hypogammaglobulinemia. Ann Allergy Asthma Immunol. 1997;78:313–8.PubMedCrossRef
66.
Magen E, Schlesinger M, Ben-Zion I, Vardy D. Helicobacter pylori infection in patients with selective immunoglobulin E deficiency. World J Gastroenterol. 2015;21:240–5.PubMedPubMedCentralCrossRef
67.
McVicker S, Karim MY. IgE deficiency may indicate underlying hypogammaglobulinaemia? J Clin Pathol. 2014;67:832–3.PubMedCrossRef
68.
Barton JC, Barton JC, Bertoli LF. Hypogammaglobulinemia E in 216 adults with IgG subclass deficiency and respiratory tract infections. Ann Allergy Asthma Immunol. 2017;119:292–4.PubMedCrossRef
69.
Bjorkander J, Bengtsson U, Oxelius VA, Hanson LA. Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis. Monogr Allergy. 1986;20:157–63.PubMed
70.
Björkander J, Bengtsson U, Oxelius VA, Hanson LA. Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis. Monogr Allergy. 1986;20:157–63.PubMed
71.
Angum F, Khan T, Kaler J, Siddiqui L, Hussain A. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12:e8094.PubMedPubMedCentral
72.
Dinse GE, Parks CG, Weinberg CR, Co CA, Wilkerson J, Zeldin DC, et al. Increasing prevalence of antinuclear antibodies in the United States. Arthritis Rheumatol. 2020;72:1026–35.PubMedPubMedCentralCrossRef
73.
Ference EH, Tan BK, Hulse KE, Chandra RK, Smith SB, Kern RC, et al. Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis. Allergy Rhinol (Providence ). 2015;6:82–8.
74.
75.
Zhao EJ, Carruthers MN, Li CH, Mattman A, Chen LYC. Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center. Haematologica. 2020;105:e121–3.PubMedPubMedCentralCrossRef
76.
Lin S, Sun Q, Mao W, Chen Y. Serum immunoglobulin A (IgA) level Is a potential biomarker indicating cirrhosis during chronic hepatitis B infection. Gastroenterol Res Pract. 2016;2016:2495073.PubMedPubMedCentralCrossRef
77.
Crisp HC, Quinn JM. Quantitative immunoglobulins in adulthood. Allergy Asthma Proc. 2009;30:649–54.PubMedCrossRef
78.
Duarte-Rey C, Bogdanos DP, Leung PS, Anaya JM, Gershwin ME. IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev. 2012;11:A404–12.PubMedCrossRef
79.
Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151:42–50.PubMedPubMedCentralCrossRef
80.
81.
Barton J, Barton C, Bertoli L. Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency. PLoS ONE. 2019;14:e0216940.PubMedPubMedCentralCrossRef
82.
Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby GH, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38:129–43.PubMedCrossRef
83.
Fox RI, Chan E, Benton L, Fong S, Friedlaender M, Howell FV. Treatment of primary Sjögren’s syndrome with hydroxychloroquine. Am J Med. 1988;85:62–7.PubMedCrossRef
84.
Lege-Oguntoye L, Onyemelukwe GC, Maiha BB, Udezue EO, Eckerbom S. The effect of short-term malaria chemoprophylaxis on the immune response of semi-immune adult volunteers. East Afr Med J. 1990;67:770–8.PubMed
85.
Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120:225–31.PubMedPubMedCentralCrossRef
86.
Bodewes ILA, Gottenberg JE, van Helden-Meeuwsen CG, Mariette X, Versnel MA. Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial. Rheumatology (Oxford). 2020;59:107–11.CrossRef
87.
Knight AK, Cunningham-Rundles C. Oxcarbazepine-induced immunoglobulin deficiency. Clin Diagn Lab Immunol. 2005;12:560–1.PubMedPubMedCentral
88.
Aucouturier P, Mounir S, Preud’homme JL. Distribution of IgG subclass levels in normal adult sera as determined by a competitive enzyme immunoassay using monoclonal antibodies. Diagn Immunol. 1985;3:191–6.PubMed
89.
Barton JC, Bertoli LF, Acton RT. HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama. BMC Med Genet. 2003;4:3.PubMedPubMedCentralCrossRef
90.
Schauer U, Stemberg F, Rieger CH, Borte M, Schubert S, Riedel F, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003;49:1924–9.PubMedCrossRef
91.
92.
De Greef GE, Van Tol MJ, Van Den Berg JW, Van Staalduinen GJ, Janssen CJ, Radl J, et al. Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans. Mech Ageing Dev. 1992;66:29–44.PubMedCrossRef
93.
World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.CrossRef
Metadata
Title
Factors associated with IgG levels in adults with IgG subclass deficiency
Authors
James C. Barton
Jackson Clayborn Barton
Luigi F. Bertoli
Ronald T. Acton
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2021
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-021-00447-3

Other articles of this Issue 1/2021

BMC Immunology 1/2021 Go to the issue

Research

Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China

Research article

Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Research

Upregulation of PD-1 expression on circulating CD8+ but not CD4+ T cells is associated with tuberculosis infection in health care workers

Correction

Correction to: CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling

Research article

Predicting the allergenicity of legume proteins using a PBMC gene expression assay

Research article

Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits